Bank of New York Mellon’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.22M | Buy |
237,101
+7,343
| +3% | +$68.8K | ﹤0.01% | 2688 |
|
|
2025
Q1 | $2.82M | Buy |
229,758
+5,497
| +2% | +$67.5K | ﹤0.01% | 2501 |
|
|
2024
Q4 | $2.96M | Buy |
224,261
+2,759
| +1% | +$36.5K | ﹤0.01% | 2560 |
|
|
2024
Q3 | $4.26M | Sell |
221,502
-70,324
| -24% | -$1.35M | ﹤0.01% | 2374 |
|
|
2024
Q2 | $5.99M | Buy |
291,826
+46,463
| +19% | +$954K | ﹤0.01% | 2243 |
|
|
2024
Q1 | $5.84M | Buy |
245,363
+14,505
| +6% | +$345K | ﹤0.01% | 2244 |
|
|
2023
Q4 | $4.99M | Buy |
230,858
+3,354
| +1% | +$72.5K | ﹤0.01% | 2375 |
|
|
2023
Q3 | $3.3M | Sell |
227,504
-7,476
| -3% | -$109K | ﹤0.01% | 2537 |
|
|
2023
Q2 | $4.92M | Buy |
234,980
+23,257
| +11% | +$487K | ﹤0.01% | 2332 |
|
|
2023
Q1 | $4.47M | Buy |
211,723
+19,240
| +10% | +$406K | ﹤0.01% | 2364 |
|
|
2022
Q4 | $4.9M | Buy |
192,483
+3,289
| +2% | +$83.7K | ﹤0.01% | 2351 |
|
|
2022
Q3 | $4.55M | Buy |
189,194
+22,007
| +13% | +$529K | ﹤0.01% | 2334 |
|
|
2022
Q2 | $3.22M | Sell |
167,187
-9,204
| -5% | -$177K | ﹤0.01% | 2559 |
|
|
2022
Q1 | $3.07M | Buy |
176,391
+9,819
| +6% | +$171K | ﹤0.01% | 2693 |
|
|
2021
Q4 | $3.65M | Sell |
166,572
-1,778
| -1% | -$38.9K | ﹤0.01% | 2629 |
|
|
2021
Q3 | $3.22M | Buy |
168,350
+21,405
| +15% | +$409K | ﹤0.01% | 2726 |
|
|
2021
Q2 | $2.52M | Buy |
146,945
+16,430
| +13% | +$282K | ﹤0.01% | 2843 |
|
|
2021
Q1 | $2.92M | Hold |
130,515
| – | – | ﹤0.01% | 2705 |
|
|
2020
Q4 | $2.9M | Buy |
130,515
+26,956
| +26% | +$600K | ﹤0.01% | 2629 |
|
|
2020
Q3 | $1.53M | Buy |
103,559
+18
| +0% | +$266 | ﹤0.01% | 2840 |
|
|
2020
Q2 | $1.53M | Buy |
103,541
+20,919
| +25% | +$310K | ﹤0.01% | 2836 |
|
|
2020
Q1 | $906K | Buy |
82,622
+7,635
| +10% | +$83.7K | ﹤0.01% | 3051 |
|
|
2019
Q4 | $658K | Buy |
74,987
+2,642
| +4% | +$23.2K | ﹤0.01% | 3447 |
|
|
2019
Q3 | $540K | Buy |
72,345
+1,446
| +2% | +$10.8K | ﹤0.01% | 3489 |
|
|
2019
Q2 | $659K | Buy |
70,899
+4,837
| +7% | +$45K | ﹤0.01% | 3460 |
|
|
2019
Q1 | $347K | Buy |
66,062
+1,026
| +2% | +$5.39K | ﹤0.01% | 3685 |
|
|
2018
Q4 | $289K | Buy |
65,036
+15,274
| +31% | +$67.9K | ﹤0.01% | 3728 |
|
|
2018
Q3 | $402K | Sell |
49,762
-30,610
| -38% | -$247K | ﹤0.01% | 3728 |
|
|
2018
Q2 | $564K | Buy |
80,372
+33,892
| +73% | +$238K | ﹤0.01% | 3577 |
|
|
2018
Q1 | $661K | Buy |
46,480
+1,304
| +3% | +$18.5K | ﹤0.01% | 3434 |
|
|
2017
Q4 | $396K | Sell |
45,176
-2,356
| -5% | -$20.7K | ﹤0.01% | 3699 |
|
|
2017
Q3 | $556K | Buy |
47,532
+3,507
| +8% | +$41K | ﹤0.01% | 3532 |
|
|
2017
Q2 | $615K | Buy |
44,025
+14,798
| +51% | +$207K | ﹤0.01% | 3505 |
|
|
2017
Q1 | $401K | Buy |
29,227
+8,861
| +44% | +$122K | ﹤0.01% | 3640 |
|
|
2016
Q4 | $146K | Buy |
20,366
+3,725
| +22% | +$26.7K | ﹤0.01% | 3959 |
|
|
2016
Q3 | $253K | Buy |
+16,641
| New | +$253K | ﹤0.01% | 3826 |
|